The use of magnetic resonance cell tracking to monitor endothelial progenitor cells in a rat hindlimb ischemic model

Biomaterials

Volumn 33, Issue 8, 2012, Pages 2439-2448

  Agudelo, Carlos A ^a   Tachibana, Yoichi ^a   Hurtado, Andres F ^a   Ose, Takayuki ^a   Iida, Hidehiro ^a   Yamaoka, Tetsuji ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Dextran; MRI; Progenitor cell; Transplantation

Indexed keywords

CELL TRACKING; ENDOTHELIAL PROGENITOR CELLS; HIND LIMBS; ISCHEMIC LIMBS; ISCHEMIC TISSUES; MAGNETIC RESONANCE IMAGING CONTRAST AGENTS; MRI CONTRAST AGENTS; PROGENITOR CELL; STEM CELL TRANSPLANTATION;

CELL DEATH; DEXTRAN; ENDOTHELIAL CELLS; GADOLINIUM; MAGNETIC RESONANCE IMAGING; RATS; TISSUE; TRANSPLANTATION (SURGICAL);

STEM CELLS;

CONTRAST MEDIUM; DEXTRAN MONO N SUCCINIMIDYL 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETATE GADOLINIUM; GADOTERIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEATH; CELL FATE; CELL LABELING; CELL MIGRATION; CELL SURVIVAL; CELL TRACKING; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; ENGRAFTMENT; FEMUR; HINDLIMB ISCHEMIA; HUMAN; INGUINAL REGION; LIMB ISCHEMIA; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; STEM CELL TRANSPLANTATION;

ANIMALS; CELL MOVEMENT; CELL TRACKING; DEXTRANS; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; GADOLINIUM; HETEROCYCLIC COMPOUNDS; HINDLIMB; IMAGING, THREE-DIMENSIONAL; ISCHEMIA; MAGNETIC RESONANCE SPECTROSCOPY; MALE; ORGANOMETALLIC COMPOUNDS; RATS; RATS, INBRED F344; REGIONAL BLOOD FLOW; STEM CELL TRANSPLANTATION; STEM CELLS; WOUND HEALING;

RATTUS;

EID: 84855843024     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.11.075     Document Type: Article

References (42)

1. Rafii S., Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003, 9:702-712.
2. Kondo K., Shintani S., Shibata R., Murakami H., Murakami R., Imaizumi M., et al. Implantation of adipose-derived regenerative cell enhances ischemia induced angiogenesis. Arterioscler Thromb Vasc Biol 2009, 29:61-66.
3. Murohara T. Autologous adipose tissue as a new source of progenitor cells for therapeutic angiogenesis. JCardiol 2009, 53:155-163.
4. Shintani S., Murohara T., Ikeda H., Ueno T., Sasaki K., Duan J., et al. Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation 2001, 103:897-903.
5. Hida N., Nishiyama N., Miyoshi S., Kira S., Segawa K., Uyama T., et al. Novel cardiac precursor-like cells from human menstrual blood-derived mesenchymal cells. Stem Cells 2008, 26:1695-1704.
6. Iba O., Matsubara H., Nozawa Y., Fujiyama S., Amano K., Mori Y., et al. Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs. Circulation 2002, 106:2019-2025.
7. Kocher A.A., Schuster M.D., Szabiolcs M.J., Takuma S., Burkhoff D., Wang J., et al. Neovascularization of ischemic myocardium by human bone marrow derived angioblast prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001, 7:430-436.
8. Leobon B., Roncalli J., Joffre C., Mazo M., Boisson M., Barreau C., et al. Adipose-derived cardiomyogenic cells: invitro expantion and functional improvement in a mouse model of myocardial infarction. Cardiovasc Res 2009, 83:757-767.
9. Rafii S., Meeus S., Dias S., Hattori K., Heissig B., Shemelkov S., et al. Contribution of morrow-derived progenitors to vascular and cardiac regeneration. Cell Devl Biol 2002, 13:61-67.
10. Risau W. Mechanism of angiogenesis. Nature 1997, 386:671-674.
11. Folkman J., D'Amore P.A. Blood vessel formation: what is its molecular basis?. Cell 1996, 87:1153-1155.
12. Asahara T., Masuda H., Takahashi T., Kalka C., Pastore C., Silver M., et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999, 85:221-228.
13. Shi Q., Rafii S., Wu M.H., Wijelath E.S., Cong Y., Ishida A., et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998, 92:362-367.
14. 165 gene transfer augments circulating endothelial progenitor cells in human subjects. Circ Res 2000, 86:1198-1202.
15. Asahara T., Murohara T., Sullivan A., Silver M., Zee R.V.D., Li T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 274:964-967.
16. Iwaguro H., Yamaguchi J.I., Kalka C., Murasawa S., Masuda H., Hayashi S.I., et al. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 2002, 105:732-738.
17. Lyden D., Hattori K., Dias S., Costa C., Blaikie P., Butros L., et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2001, 7:1194-1200.
18. Kalka C., Masuda H., Takahashi T., Kalka-Moll W.M., Silver M., Kearney M., et al. Transplantation of exvivo explanted endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 2000, 28:3422-3427.
19. Urbich C., Aicher A., Heeschen C., Dernbach E., Hofmann W.K., Zeiher A.M., et al. Soluble factors released by endothelial cells and cardiac resident progenitor cells. JMol Cell Cardiol 2005, 39:733-742.
20. Urbich C., Dimmeler S. Endothelial progenitor cells characterization and role in vascular biology. Circ Res 2004, 95:343-353.
21. Urbich C., Heesechen C., Aicher A., Dernbach E., Zeiher A.M., Dimmeler S. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 2003, 108:2511-2516.
22. Lewin M., Carlesso N., Tung C.H., Tang T.X., Cory D., Scadden D.T., et al. Tat peptide-derivatized magnetic nanoparticles allow invivo tracking and recovery of progenitor cells. Nat Biotechnol 2000, 18:410-414.
23. Wilhelm C., Bal L., Smirnov V., Galy-Fauroux I., Clement O., Gazeau F., et al. Magnetic control of vascular network formation with magnetically labeled endothelial progenitor cells. Biomaterials 2007, 28:3797-3806.
24. Bulte J.W.M., Douglas T., Witwer B., Zhang S.C., Strable E., Lewis B.K., et al. Magnetodendrimers allow endosomal magnetic labeling and invivo tracking of stem cells. Nat Biotechnol 2001, 19:1141-1147.
25. Guzman R., Uchida N., Bliss T.M., He D., Christopherson K.K., Stellwagen D., et al. Long term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI. Proc Natl Acad Sci USA 2007, 104:10211-10216.
26. Hoehn M., Küstermann E., Blunk J., Wiedermann D., Trapp T., Wecker S., et al. Monitoring of implanted stem cell migration invivo: a highly resolved invivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci USA 2002, 25:16267-16272.
27. Amsalem Y., Mardor Y., Feinberg M.S., Landa N., Miller L., Daniels D., et al. Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium. Circulation 2007, 116:I.38-I.45.
28. Terrovitis J., Stuber M., Youssef A., Preece S., Leppo M., Kizana E., et al. Magnetic resonance imaging overestimates ferumoxide-labeled stem cell survival after transplantation in the heart. Circulation 2008, 117:1555-1562.
29. Li Z., Suzuki Y., Huang M., Cao F., Xie X., Connolly A.J., et al. Comparison of reporter gene and iron particle labeling for tracking fate of human embryonic stem cells and differentiated endothelial cells in living subjects. Stem Cells 2008, 26:864-873.
30. Winter E.M., Hogers B., Van der Graaf L.M., Gittenberger-de Groot A.C., Poelmann R., Van der Weerd L. Cell tracking using iron oxide fails to distinguish dead from living transplanted cells in the infracted heart. Magn Reson Med 2010, 63:817-821.
31. Tachibana Y., Enmi J.I., Mahara A., Iida H., Yamaoka T. Design and characterization of a polymeric MRI contrast agent based on PVA for invivo living-cell tracking. Contrast Media Mol Imaging 2010, 5:309-317.
32. Yamaoka T., Tabata Y., Ikada Y. The fate of water-soluble polymers administered through different routes. JPharm Sci 1995, 84:349-354.
33. Yamaoka T., Tabata Y., Ikada Y. Blood clearance and organ distribution of intravenously administered polystyrene microspheres of different sizes. JBioact Compat Polym 1993, 8:220-235.
34. Yamaoka T., Tabata Y., Ikada Y. Body distribution profile of polysaccharides after intravenous administration. Drug Deliv 1993, 1:75-82.
35. Agudelo C.A., Tachibana Y., Noboru T., Iida H., Yamaoka Y. Long-term invivo magnetic resonance imaging tracking of endothelial progenitor cells transplanted in rat ischemic limbs and their angiogenic potential. Tissue Eng 2011, 15-16:2079-2089.
36. Takahashi T., Kalka C., Masuda H., Chen D., Silver M., Kearney M., et al. Ischemia-and cytokine-induced mobilization of bone marrow- derived endothelial progenitor cells for neovascularization. Nat Med 1999, 5:434-438.
37. Takeshita S., Takaaki I., Mori H., Tanaka E., Eto K., Miyazawa Y., et al. Use of synchrotron radiation microangiography to assess development of small collateral arteries in a rat model of hindlimb ischemia. Circulation 1997, 95:805-808.
38. Ikenaga S., Hamano K., Nishida M., Kobayashi T., Li T., Kobayashi S., et al. Autologous bone marrow implantation induced angiogenesis and improved deteriorated exercise capacity in a rat ischemic hindlimb model. JSurg Res 2001, 96:277-283.
39. Marckmann P., Skov L., Rossen K., Dupont A., Damholt M.B., Heaf J.G., et al. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. JAm Soc Nephrol 2006, 17:2359-2362.
40. Nissen N.N., Polverini P.J., Koch A.E., Volin M.V., Gamelli R.L., DiPietro L.A. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol 1998, 152:1445-1452.
41. Daldrun-Link H.E., Rudelius M., Metz S., Brauer R., Debus G., Corot C., et al. Migration of iron oxide labeled human hematopoietic progenitor cells in a mouse model: invivo monitoring with 1.5-T MR imaging equipement. Radiol 2005, 234:197-205.
42. Caravan P., Ellison J.J., McMurry T.J., Lauffer R.B. Gadolinium (III) chelates as MRI contrast agent: structure, dynamics, and applications. Chem Rev 1999, 99:2293-2352.